MELD-Na评分对肝硬化患者血脂和预后的影响

doi:10.3969/j.issn.1672-5069.2016.06.027

Abstract

Zhang Gaizhen，Ren Jianjun.. Lipid levels and MELD-Na scores in patients with liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 732-733.

[1] Stasi C，Silvestri C，Voller F，et al. Epidemiology of liver cirrhosis. J Clin Exp Hepatol，2015，5（3）:272-276.
[2] Scaglione S，Kliethermes S，Cao G，et al. The Epidemiology of cirrhosis in the United States:A population-based study. J Clin Gastroenterol，2015，49（8）:690-696.
[3] Kim KA，Ki M，Choi HY，et al. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther，2016，43（1）:154-162.
[4] Zhang X，Qi X，De Stefano V，et al. Epidemiology，risk factors，and in-hospital mortality of venous thromboembolism in liver cirrhosis:A single-center retrospective observational study. Med Sci Monit，2016，22（4）:969-976.
[5] Cook MR，Fair KA，Burg J，et al. Cirrhosis increases mortality and splenectomy rates following splenic injury. Am J Surg，2015，209（5）:841-847.
[6] Kanwal F. Decreasing mortality in patients hospitalized with cirrhosis. Gastroenterology，2015，148（5）:897-900.
[7] Bittencourt PL，Farias AQ，Terra C. Renal failure in cirrhosis: Emerging concepts. World J Hepatol，2015，7（21）:2336-2343.
[8] Sola E，Gines P. Challenges and management of liver cirrhosis:Pathophysiology of renal dysfunction in cirrhosis. Dig Dis，2015，33（4）:534-538.
[9] Silveira KC，Viau CM，Colares JR，et al. Cirrhosis induces apoptosis in renal tissue through intracellular oxidative stress. Arq Gastroenterol，2015，52（1）:65-71.
[10] Gharipour M，Sadeghi M，Dianatkhah M，et al. Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes. J Clin Lipidol，2016，10（1）:143-149.
[11] Blum AP，Kammeyer JK，Gianneschi NC. Activating peptides for cellular uptake via polymerization into high density brushes. Chem Sci，2016，7（2）:989-994.
[12] Verbeek R，Hovingh GK，Boekholdt SM. Non-high-density lipoprotein cholesterol:current status as cardiovascular marker. Curr Opin Lipidol，2015，26（6）:502-510.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Tang Renyi, Hu Qunfeng, Peng Liqing.. Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(6): 860-863.
[3]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[4]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[5]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Liu Li, Yang Lie, Chen Haiyang, et al.. Changes of hemodynamics after splenectomy combined with pericardial devascularization in patients with cirrhotic portal hypertention complicated by splenic artery steal syndrome [J]. Journal of Practical Hepatology, 2019, 22(6): 884-887.
[8]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[9]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[10]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[11]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[12]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[13]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[14]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[15]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.

Lipid levels and MELD-Na scores in patients with liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments